Effectiveness and Safety of Lemborexant Over 12 Months in Adults with Insomnia Disorder: Longterm Results From the Phase 3 SUNRISE-2 Study

被引：0
|
作者：
Yardley, Jane [1 ]
Karppa, Mikko [2 ,3 ]
Inoue, Yuichi [4 ]
Pinner, Kate [1 ]
Perdomo, Carlos [5 ]
Filippov, Gleb [5 ]
Kubota, Naoki [6 ]
Moline, Margaret [5 ]
机构：
[1] Eisai Ltd, Bunkyo City, Japan
[2] Oulu Univ Hosp, Oulu, Finland
[3] Univ Oulu, Oulu, Finland
[4] Tokyo Med Univ, Tokyo, Japan
[5] Eisai Inc, Bunkyo City, Japan
[6] Eisai & Co Ltd, Bunkyo City, Japan
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
420
引用
收藏
页数：3
相关论文
共 50 条
  • [1] LONG-TERM EFFECTIVENESS AND SAFETY OF LEMBOREXANT IN ADULTS WITH INSOMNIA DISORDER: 12-MONTH RESULTS FROM SUNRISE-2
    Yardley, J.
    Karppa, M.
    Inoue, Y.
    Pinner, K.
    Perdomo, C.
    Filippov, G.
    Kubota, N.
    Moline, M.
    [J]. SLEEP MEDICINE, 2019, 64 : S263 - S264
  • [2] LONG-TERM EFFICACY AND SAFETY OF LEMBOREXANT IN ELDERLY ADULTS WITH INSOMNIA DISORDER: RESULTS FROM SUNRISE-2
    Moline, M.
    Inoue, Y.
    Pinner, K.
    Perdomo, C.
    Filippov, G.
    Kubota, N.
    Yardley, J.
    [J]. SLEEP, 2020, 43 : A182 - A182
  • [3] Impact of Lemborexant Treatment on Insomnia Disease Severity and Fatigue: Results from the 12-Month Phase 3 Study SUNRISE-2
    Moline, Margaret
    Karppa, Mikko
    Yardley, Jane
    Kumar, Dinesh
    Pinner, Kate
    Perdomo, Carlos
    Filippov, Gleb
    Atkins, Norman
    [J]. NEUROLOGY, 2020, 94 (15)
  • [4] Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia Disorder: Pooled Analyses from SUNRISE-1 and SUNRISE-2
    Moline, Margaret
    Yardley, Jane
    Pinner, Kate
    Kumar, Dinesh
    Bsharat, Mohammed
    Karppa, Mikko
    Zammit, Gary
    Perdomo, Carlos
    Mianulli, Caroline
    Rosenberg, Russell
    [J]. NEUROLOGY, 2020, 94 (15)
  • [5] EFFECTIVENESS AND SAFETY OF LEMBOREXANT IN SUBJECTS PREVIOUSLY TREATED WITH PLACEBO FOR 6 MONTHS IN SUNRISE-2
    Yardley, J.
    Inoue, Y.
    Pinner, K.
    Perdomo, C.
    Filippov, G.
    Kubota, N.
    Moline, M.
    [J]. SLEEP, 2020, 43 : A181 - A182
  • [6] SLEEP ONSET AND SLEEP MAINTENANCE RESPONDER PROFILES OVER 12 MONTHS OF TREATMENT WITH LEMBOREXANT: RESULTS FROM SUNRISE-2
    Zammit, G.
    Yardley, J.
    Pinner, K.
    Moline, M.
    [J]. SLEEP, 2020, 43 : A184 - A184
  • [7] SAFETY OF LEMBOREXANT IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)
    Rosenberg, Russell
    Filippov, Gleb
    LoPresti, Antonia
    Kumar, Dinesh
    Murphy, Patricia
    Moline, Margaret
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S155 - S156
  • [8] Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
    Yardley, Jane
    Karppa, Mikko
    Inoue, Yuichi
    Pinner, Kate
    Perdomo, Carlos
    Ishikawa, Kohei
    Filippov, Gleb
    Kubota, Naoki
    Moline, Margaret
    [J]. SLEEP MEDICINE, 2021, 80 : 333 - 342
  • [9] Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
    Karppa, Mikko
    Yardley, Jane
    Pinner, Kate
    Filippov, Gleb
    Zammit, Gary
    Moline, Margaret
    Perdomo, Carlos
    Inoue, Yuichi
    Ishikawa, Kohei
    Kubota, Naoki
    [J]. SLEEP, 2020, 43 (09) : 1 - 11
  • [10] Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder
    Roth, Thomas
    Rosenberg, Russell
    Morin, Charles M.
    Yardley, Jane
    Pinner, Kate
    Perdomo, Carlos
    Atkins, Norman, Jr.
    Pappadopulos, Elizabeth
    Malhotra, Manoj
    Moline, Margaret
    [J]. SLEEP MEDICINE, 2022, 90 : 249 - 257
12345